Indivior added to S&P SmallCap 600 index effective December 22, 2025

Indivior Pharmaceuticals, Inc.

Inclusion in S&P SmallCap 600 index effective today, December 22, 2025.
CEO Joe Ciaffoni cites alignment with sharpened U.S. business profile and commitment to SUBLOCADE.
S&P SmallCap 600 comprises 600 U.S. small-cap companies with market caps between $1.2B and $8.0B.
Addition expected to increase visibility and potential passive fund inflows for INDV shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.